Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B

Elizabeth Hopper-Borge1, Xiu Xu, Tong Shen

  • 1Medical and Basic Science Divisions, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Cancer Research
|January 2, 2009
PubMed

Insights

Multidrug resistance protein 7 (MRP7) confers resistance to anticancer drugs like docetaxel and nucleoside agents such as cytarabine. This efflux pump

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Cancer Research

Background:

  • Multidrug resistance protein 7 (MRP7; ABCC10) is an ATP-binding cassette transporter.
  • MRP7 confers resistance to certain chemotherapy drugs, but its full substrate profile is not well-defined.

Purpose of the Study:

  • To comprehensively characterize the drug resistance profile of MRP7.
  • To determine if MRP7 transports nucleoside-based agents and other natural products.

Main Methods:

  • Analysis of MRP7-transfected HEK293 cells.
  • Ectopic expression of MRP7 in drug-sensitive mouse embryo fibroblasts (deficient in P-glycoprotein and Mrp1).
  • Drug accumulation assays for cytarabine (Ara-C) and PMEA.
  • Assessment of resistance levels to various anticancer agents.

Main Results:

  • MRP7 confers resistance to nucleoside-based agents (cytarabine, gemcitabine) and antiviral nucleosides (2',3'-dideoxycytidine, PMEA).
  • MRP7 expression reduced the intracellular accumulation of Ara-C and PMEA, consistent with an efflux mechanism.
  • MRP7 demonstrated broad resistance to natural product anticancer agents, including high resistance to docetaxel (46-fold), paclitaxel (116-fold), SN-38 (65-fold), and vincristine (56-fold).
  • Resistance to docetaxel and Ara-C was not affected by buthionine sulfoximine, indicating glutathione independence.

Conclusions:

  • MRP7 possesses a broad drug resistance profile, extending beyond known substrates to include nucleoside-based agents.
  • MRP7 mediates the transport of natural product anticancer agents, including non-taxane antimicrotubules, independent of P-glycoprotein.
  • MRP7-mediated drug transport does not involve glutathione, differentiating it from MRP1 and MRP2.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types: